NexgenRx Inc.

NexgenRx Inc.

July 18, 2007 11:25 ET

NexgenRx Announces Board Changes

TORONTO, ONTARIO--(Marketwire - July 18, 2007) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") announces the appointment of Mr. David Rosenkrantz, MBA, P.Eng as a member of the Corporation's Audit Committee. The Corporation further announces that it has received the resignation of Mr. Michel LeBel as a director of the Corporation. The Corporation has expressed its sincere gratitude to Mr. LeBel for his service throughout his term and wishes him continued success in all of his future endeavours. The Corporation will examine whether or not to fill the vacancy on the board created by this resignation and may, at some future time, appoint a replacement director in the event that it is determined that an additional director is required and provided that a suitable party can be identified.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. NexgenRx provides an efficient, cost-effective alternative to insurers for those Canadian plan sponsors who are providing, or wish to provide, an adminstration services only, or "ASO" health benefit plan to their plan members. NexgenRx also provides a competitive alternative for the provision of health benefit claims adjudication services to third party administrators who manage and administer benefit plans on behalf of a number of plan sponsors and whose services to such plan sponsors include, but are not limited to, the adjudication and payment of health benefit claims made under the plans managed and administered by them.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)
    NexgenRx Inc.
    Jeff Dawley
    VP Finance, CFO and Corporate Secretary
    (416) 695-3393 x 803
    (647) 722-2921 (FAX)